Читать книгу Biologics, Biosimilars, and Biobetters - Группа авторов - Страница 44

This initiative was announced in 2015 as part of the Australian Pharmaceutical Benefits Scheme (PBS) Access and Sustainability Package. The aim is to support awareness of, and confidence in, the use of biosimilar medicines for healthcare professionals and consumers.⁷⁴

Several research activities like up‐to‐date literature review⁷⁵ form part of the initiative; these aim to separate the evidence from commentary better; gather data on current awareness and attitudes toward innovator biologics and biosimilars in Australia; and identify critical issues, like barriers to uptake and use of biosimilars.